Low-Intensity Monitoring After Stroke Thrombolysis During the COVID-19 Pandemic

[1]  P. Lyden.  Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic. , 2020, Stroke.

[2]  Megan L Ranney,et al.  Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. , 2020, The New England journal of medicine.

[3]  Robert D Truog,et al.  The Toughest Triage - Allocating Ventilators in a Pandemic. , 2020, The New England journal of medicine.

[4]  M. Saheed,et al.  Safety Trial of Low-Intensity Monitoring After Thrombolysis: Optimal Post Tpa-Iv Monitoring in Ischemic STroke (OPTIMIST) , 2020, The Neurohospitalist.

[5]  E. Marsh,et al.  Resource Allocation: Stable Patients Remain Stable 12–24 h Post-tPA , 2019, Neurocritical Care.

[6]  Correction to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[7]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[8]  Keith W. Muir,et al.  Do Clinicians Overestimate the Severity of Intracerebral Hemorrhage? , 2019, Stroke.

[9]  Karen Chen,et al.  Shorter Intensive Care Unit Stays?: The Majority of Post-Intravenous tPA (Tissue-Type Plasminogen Activator) Symptomatic Hemorrhages Occur Within 12 Hours of Treatment , 2018, Stroke.

[10]  R. Gottesman,et al.  ICAT: a simple score predicting critical care needs after thrombolysis in stroke patients , 2015, Critical Care.

[11]  L. Schwamm,et al.  Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study. , 2015, JAMA neurology.

[12]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .

[13]  V. Urrutia,et al.  Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke , 2014, PloS one.

[14]  Eric E. Smith,et al.  Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator , 2012, Stroke.

[15]  Eric E. Smith,et al.  Outcomes in Mild or Rapidly Improving Stroke Not Treated With Intravenous Recombinant Tissue-Type Plasminogen Activator: Findings From Get With The Guidelines–Stroke , 2011, Stroke.

[16]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[17]  Werner Hacke,et al.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.

[18]  M. Hadley,et al.  Recommendations for Comprehensive Stroke Centers: A Consensus Statement From the Brain Attack Coalition , 2005, Stroke.

[19]  G. Kongable,et al.  Nursing Care Of Acute Stroke Patients After Receiving rt‐PA Therapy , 1997, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[20]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[21]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .